Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study)

INTRODUCTION: SARS-CoV-2 pneumonia is often associated with hyper-inflammation. The cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 (COVID-19). High Interleukin-6 (IL6) blood levels have been identified in severe COVID-19 disease, but there are still uncer...

Descripción completa

Detalles Bibliográficos
Autores principales: Sancho-López, Aránzazu, Caballero-Bermejo, Antonio F., Ruiz-Antorán, Belén, Múñez Rubio, Elena, García Gasalla, Mercedes, Buades, Juan, González Rozas, Marta, López Veloso, María, Muñoz Gómez, Ana, Cuenca Abarca, Ana, Durán del Campo, Pedro, Ibáñez, Fátima, Díaz de Santiago, Alberto, Romero, Yolanda, Calderón, Jorge, Pintos, Ilduara, Ferre Beltrán, Adrián, Centeno Soto, Gustavo, Campos, José, Ramos Martínez, Antonio, Avendaño-Solá, Cristina, Fernández Cruz, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520759/
https://www.ncbi.nlm.nih.gov/pubmed/34658006
http://dx.doi.org/10.1007/s40121-021-00543-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520759/
https://www.ncbi.nlm.nih.gov/pubmed/34658006
http://dx.doi.org/10.1007/s40121-021-00543-2

Ejemplares similares